#5B;(1-R)-(1,3,5/2,4)-5-O-(BETA-D-GLUCOPYRANOSYLOXYMETHYL)-2,3,4-TRIHYDROXY-N-[(1-S)-(1,4,6/5)-3-HYDROXYMETHYL-4,5,6-TRIHYDROXYCYCLOHEX-2-ENYL]-CYCLOHEXYLAMINE
Compound with spectra: 1 NMR
![#5B;(1-R)-(1,3,5/2,4)-5-O-(BETA-D-GLUCOPYRANOSYLOXYMETHYL)-2,3,4-TRIHYDROXY-N-[(1-S)-(1,4,6/5)-3-HYDROXYMETHYL-4,5,6-TRIHYDROXYCYCLOHEX-2-ENYL]-CYCLOHEXYLAMINE](/api/compound/1UMYPywSrnN.png?ph=true&h=300&w=458 "#5B;(1-R)-(1,3,5/2,4)-5-O-(BETA-D-GLUCOPYRANOSYLOXYMETHYL)-2,3,4-TRIHYDROXY-N-[(1-S)-(1,4,6/5)-3-HYDROXYMETHYL-4,5,6-TRIHYDROXYCYCLOHEX-2-ENYL]-CYCLOHEXYLAMINE")
| SpectraBase Compound ID | 1UMYPywSrnN |
|---|---|
| InChI | InChI=1S/C20H35NO13/c22-3-6-1-8(13(26)16(29)11(6)24)21-9-2-7(12(25)17(30)14(9)27)5-33-20-19(32)18(31)15(28)10(4-23)34-20/h1,7-32H,2-5H2/t7-,8-,9-,10-,11+,12-,13-,14+,15-,16-,17+,18+,19-,20-/m0/s1 |
| InChIKey | DZOSEJASWWCMOA-BQQUXRDBSA-N |
| Mol Weight | 497.5 g/mol |
| Molecular Formula | C20H35NO13 |
| Exact Mass | 497.21084 g/mol |
| Enantiomer InChIKey | DZOSEJASWWCMOA-IIJKXRBDSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | D2O |
7'-O-BETA-D-GLUCOPYRANOSYL-VALIDOXYLAMINE-A
9-O-[[BETA-D-GLUCOPYRANOSYL-(1->6)-[BETA-D-GLUCOPYRANOSYL-(1->2)]-BETA-D-GLUCOPYRANOSYL]-HYDROXYBUTYL]-1,1,5-TRIMETHYL-4-CYCLOHEXEN-3-ONE
DENDRONOBILOSIDE-B;6-ALPHA,10,12-TRIHYDROXYPICROTOXANE-10-O-BETA-D-GLUCOPYRANOSIDE
6'-O-BETA-GLUCOPYRANOSYL-SECOLOGANOL
4-O-hexopyranosyl-N-(4-methyl-3-nitrophenyl)hexopyranosylamine
7,8-DEHYDRO-HARPAGIDE
(7R,8S,7'R,8'S)-NEO-OLIVIL-9'-O-BETA-D-GLUCOPYRANOSIDE
(7R,8S,7'R,8'S)-NEO-OLIVIL 9'-O-B-D-GLUCOSIDE
REL-(7R,8S,7'S,8'R)-4,9,4',9'-TETRAHYDROXY-3,3'-DIMETHOXY-7,7'-EPOXYLIGNAN-9-O-BETA-D-GLUCOPYRANOSIDE
| Title | Journal or Book | Year |
|---|---|---|
| All eight possible mono-.BETA.-D-glucosides of validoxylamine A. I. Preparation and structure determination. | The Journal of Antibiotics | 1991 |